Telomerase and breast cancer
Current therapies for breast cancer include treatments that are toxic and often result in drug resistance. Telomerase, a cellular reverse transcriptase that maintains the ends of chromosomes (telomeres), is activated in the vast majority of breast cancers (over 90% of breast carcinomas) but not in n...
Сохранить в:
| Опубликовано в:: | Breast Cancer Res |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMC
2001
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC138678/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11305948/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/bcr288 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|